Wave Life Sciences (WVE) Tax Provisions (2014 - 2023)
Wave Life Sciences' (WVE) quarterly Tax Provisions came in at $23000.0 in Q4 2023, down 96.62% YoY from $681000.0 in Q4 2022, and up 103.29% on a QoQ basis from -$700000.0 in Q3 2023.
Wave Life Sciences (WVE) Tax Provisions (2014 - 2023) Analysis & Trends
Wave Life Sciences (WVE) has 9 years of Tax Provisions data on file, last reported at $23000.0 in Q4 2023.
- Quarterly Tax Provisions fell 96.62% year-over-year to $23000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $23000.0 (up 221.05% YoY) and the FY2023 annual result came in at -$677000.0, down 199.41% from the prior year.
- Tax Provisions grew to $23000.0 in Q4 2023, from -$700000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $681000.0 in Q4 2022 to a low of -$841000.0 in Q4 2020.
- A 4-year average of -$208200.0 and a median of -$204000.0 in 2021 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions soared 433.82% — and 2023, when it sank 96.62%.
- Tracing WVE's Tax Provisions over 4 years: stood at -$841000.0 in 2020, then surged by 75.74% to -$204000.0 in 2021, then soared by 433.82% to $681000.0 in 2022, then slumped by 96.62% to $23000.0 in 2023.
- The last three Tax Provisions figures came in at $23000.0 (Q4 2023), -$700000.0 (Q3 2023), and $681000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Dec 31, 2022 | 681,000.00 |
| Dec 31, 2021 | -200,000.00 |
| Dec 31, 2020 | -841,000.00 |
| Dec 31, 2018 | -131,000.00 |
| Mar 31, 2018 | 172,000.00 |
| Dec 31, 2017 | -1.10 Mn |
| Sep 30, 2017 | -418,000.00 |
| Jun 30, 2017 | 343,000.00 |
| Mar 31, 2017 | 1.11 Mn |
| Dec 31, 2016 | 753,000.00 |
| Sep 30, 2016 | 384,000.00 |
| Jun 30, 2016 | 48,000.00 |
| Mar 31, 2016 | -5,000.00 |
| Dec 31, 2015 | -174,000.00 |
| Sep 30, 2015 | 83,000.00 |
| Jun 30, 2015 | 49,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Dec 31, 2014 | -10,000.00 |